These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1152617)

  • 21. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dopamine β-hydroxylase inhibitor, nepicastat, reduces different alcohol-related behaviors in rats.
    Colombo G; Maccioni P; Vargiolu D; Loi B; Lobina C; Zaru A; Carai MA; Gessa GL
    Alcohol Clin Exp Res; 2014 Sep; 38(9):2345-53. PubMed ID: 25257286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dopamine β-hydroxylase inhibitor, nepicastat, suppresses chocolate self-administration and reinstatement of chocolate seeking in rats.
    Zaru A; Maccioni P; Colombo G; Gessa GL
    Br J Nutr; 2013 Oct; 110(8):1524-33. PubMed ID: 23561307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology of thiono-sulfur compounds.
    Neal RA; Halpert J
    Annu Rev Pharmacol Toxicol; 1982; 22():321-39. PubMed ID: 7044288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation.
    Devoto P; Fattore L; Antinori S; Saba P; Frau R; Fratta W; Gessa GL
    Addict Biol; 2016 Jan; 21(1):61-71. PubMed ID: 25135633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase.
    Palatini P; Dabbeni-Sala F; Finotti P
    Biochem Int; 1984 Dec; 9(6):675-82. PubMed ID: 6525203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism and kinetics of the inhibition of dopamine-beta-hydroxylase by 2-mercaptoethylguanidine.
    Diliberto EJ; DiStefano V; Smith JC
    Biochem Pharmacol; 1973 Dec; 22(23):2961-72. PubMed ID: 4761561
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.
    Aunis D; Miras-Portugal MT; Mandel P
    Biochem Pharmacol; 1973 Oct; 22(20):2581-9. PubMed ID: 4763594
    [No Abstract]   [Full Text] [Related]  

  • 29. Further studies on irreversible inhibition of dopamine-beta-hydroxylase by cysteine.
    Izumi H; Hayakari M; Ozawa H
    Tohoku J Exp Med; 1976 Apr; 118(4):373-80. PubMed ID: 936210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of anti-thyroid agents, methimazole and propylthiouracil, on brain noradrenaline content.
    Hashizume Y; Yamaki T; Hidaka H
    Br J Pharmacol; 1977 Jan; 59(1):157-62. PubMed ID: 836996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence and some properties of a protein-like inhibitor of dopamine beta-hydroxylase in rat liver.
    Oyama H; Izumi H; Ozawa H; Tuboi S
    Biochem Pharmacol; 1977 Nov; 26(21):1985-90. PubMed ID: 336050
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of dopamine-beta-hydroxylase by alternative electron donors.
    Rosenberg RC; Gimble JM; Lovenberg W
    Biochim Biophys Acta; 1980; 613(1):62-72. PubMed ID: 7378421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.
    Loureiro AI; Bonifácio MJ; Fernandes-Lopes C; Pires N; Igreja B; Wright LC; Soares-da-Silva P
    Xenobiotica; 2015; 45(9):828-39. PubMed ID: 25915108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase.
    Kruse LI; DeWolf WE; Chambers PA; Goodhart PJ
    Biochemistry; 1986 Nov; 25(23):7271-8. PubMed ID: 3801416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse.
    Sharkawi M
    J Pharm Pharmacol; 1979 May; 31(5):340-1. PubMed ID: 37309
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of dopamine beta-hydroxylase by 2-mercapto-1-methylimidazole.
    Rosenberg RC
    Biochim Biophys Acta; 1983 Dec; 749(3):276-80. PubMed ID: 6661441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular distribution of endogenous inhibitors of dopamine -hydroxylase in bovine adrenal medulla.
    Kuzuya H; Negatsu T
    Biochem Pharmacol; 1972 Mar; 21(5):740-2. PubMed ID: 5063171
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological and metabolic interactions between ethanol and the dopamine-beta-hydroxylase inhibitor FLA 63 in mice.
    Sharkawi M
    Neuropharmacology; 1980 Mar; 19(3):277-80. PubMed ID: 6999373
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitory effect of neuropeptide Y (NPY) on the in vitro activity of dopamine-beta-hydroxylase.
    Cheng JT; Chang CL; Tsai CL
    Neurosci Lett; 1992 Feb; 136(1):36-8. PubMed ID: 1635665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.